Sight Diagnostics scoops up $71m Series D

Sight Diagnostics, an Israeli developer of blood analyzers, has raised $71 million in Series D funding.

Sight Diagnostics, an Israeli developer of blood analyzers, has raised $71 million in Series D funding. The investors were Koch Disruptive Technologies, Longliv Ventures and OurCrowd.

Source: Press Release